Intelligence · Clinical Development
Pipeline search results
Programs matching “placebo” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 588 pipeline programs matching "placebo" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
placebo (saline)
Sanofi Pasteur
Sphingomyelin Lipidosis
1 trial -
placebo for risankizumab
AbbVie
Crohn's Disease
1 trial -
placebo for risankizumab IV
AbbVie
Crohn's Disease
1 trial -
placebo plus docetaxel
Boehringer Ingelheim
Carcinoma, Non-Small-Cell Lung
1 trial -
placebo to match albiglutide
GlaxoSmithKline
Diabetes Mellitus, Type 2
1 trial -
xevinapant, Xevinapant Placebo
Merck Sharp and Dohme
Resected squamous cell carcinoma of the head and neck
1 trial -
ziltivekimab, Placebo (ziltivekimab C)
NovoThirteen
Heart failure with mildly reduced or preserved ejection fraction and systemic inflammation
1 trial -
(+)-α-DIHYDROTETRABENAZINE, ADE513 placebo
Lacuna Pharma Pty Ltd
Tardive dyskinesia
1 trial -
01-02-TL-375-015
Takeda
Drug Abuse
1 trial -
6QC-ICG, Placebo for 6QC-ICG
Disc Medicine
Breast cancer
1 trial -
ACT-1004-1239 matching placebo
Lacuna Pharma Pty Ltd
Progressive multiple sclerosis (MS)
1 trial -
ALXN 2040, Placebo matching ALXN2040
Alexion Europe SAS
Geographic atrophy (GA) secondary to Age-related Macular Degeneration (AMD)
1 trial -
ALXN 2050, ALXN2050 Placebo Tablets
Alexion Europe SAS
Lupus Nephritis (LN) Immunoglobulin A Nephropathy (IgAN)
1 trial -
AMG 133, Placebo for AMG 133
Amgen
Overweight and Obesity
1 trial -
AP707, Placebo
Lacuna Pharma Pty Ltd
Borderline personality disorder
1 trial -
APG777, Placebo
Apogee Therapeutics
Atopic Dermatitis
1 trial -
ATI-045, Placebo to ATI-045
Aclaris Therapeutics
Atopic dermatitis
1 trial -
AXATILIMAB, Placebo
Syndax Pharmaceuticals
Idiopathic pulmonary fibrosis
1 trial -
AZD0292, Placebo for AZD0292
AstraZeneca AB
Bronchiectasis with chronic pseudomonas aeruginosa colonization
1 trial -
AZD1163 Placebo, AZD1163
AstraZeneca AB
Rheumatoid arthritis
1 trial -
AZD7798 Placebo, AZD7798
AstraZeneca AB
Crohn's Disease
1 trial -
Aleniglipron or Placebo
Structure Therapeutics
Obesity, Overweight, or Chronic Weight Management
2 trials -
Alxn1920 placebo product, ALXN1920
Alexion Europe SAS
Primary Mebranous Nephropathy (PMN)
1 trial -
Amlitelimab, Placebo
Sanofi-aventis Healthcare Pty Ltd
Asthma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.